HealthLynked (HLYK) CFO George O'Leary Receives Award

What Happened

• George O'Leary, Interim Chief Financial Officer of HealthLynked Corp (HLYK), was granted 35,000 derivative securities (reported as an award/acquisition) on 2026-07-22. The grant is recorded at $0.00 (no cash paid) and is contingent on a corporate milestone rather than an immediate purchase or sale.

Key Details

• Transaction date: 2026-07-22; Form 4 filed 2026-07-24 (no late filing flag reported).
• Grant: 35,000 derivative securities reported as an award (acquisition at $0.00).
• Vesting condition (Footnote F1): Options vest in full only upon the issuer's successful approval for listing on the Nasdaq Capital Market while O'Leary is actively serving as Interim CFO.
• Holdings note (Footnote F2): Filing states these options are reported together with 2,612 warrants that have an exercise price of $6.70.
• This was an award/compensation-type grant (not an open-market purchase or sale).

Context

• Because the award vests only upon Nasdaq listing approval, there is no immediate transfer of cash value or exercised shares to sell — the grant is contingent and should be viewed as compensation tied to a corporate milestone.
• The referenced warrants (exercise price $6.70) would require payment to exercise and are separate from the contingent option award.